首页> 外文期刊>Journal of Oral Microbiology >Antibiotic susceptibility of Aggregatibacter actinomycetemcomitans JP2 in a biofilm
【24h】

Antibiotic susceptibility of Aggregatibacter actinomycetemcomitans JP2 in a biofilm

机译:聚合膜放线菌JP2在生物膜中的抗生素敏感性

获取原文
       

摘要

Background:Localizedaggressiveperiodontitis(LAgP)isaninflammatorydiseaseassociatedwithspecificbacteria,particularlyAggregatibacteractinomycetemcomitans,whichcanresultinearlytoothloss.Thebacteriagrowasabiofilmknownassubgingivalplaque.Treatmentincludesmechanicaldebridementofthebiofilm,oftenassociatedwithempiricalantibiotictreatment.Objective:TheaimsofthisstudyweretotestinvitrothesensitivityofA.actinomycetemcomitansJP2duringplanktonicandbiofilmgrowthtodoxycyclineandtothecombinationofmetronidazoleandamoxicillin,whicharetwoantibioticprotocolscommonlyusedinclinicalpractice.Design:Twoinvitrobiofilmmodelswereusedtotesttheeffectsoftheantibiotics:astatic96-wellplateassaywasusedtoinvestigatetheeffectoftheseantibioticsonbiofilmformationwhilstaflowchambermodelwasusedtoexaminetheeffectonestablishedbiofilms.Results:Oftheantibioticstestedinthismodelsystem,doxycyclinewasmostefficaciouswithaminimalinhibitoryconcentration(MIC)againstplanktoniccellsof0.21mg/Landminimalbiofilminhibitoryconcentration(MBIC)of2.10mg/L.Themostcommonlyprescribedantibioticregimen,amoxicillinmetronidazole,wasmuchlesseffectiveagainstbothplanktonicandbiofilmcellswithanMICandMBICof12.0mg/Land20.2mg/L,respectively.Asingletreatmentoftheclinicallyachievableconcentrationof10mg/LdoxycyclinetosparseA.actinomycetemcomitansbiofilmsintheflowchambermodelresultedinsignificantdecreasesinbiofilmthickness,biovolume,andcellviability.DenseA.actinomycetemcomitansbiofilmsweresignificantlymoreresistanttodoxycyclinetreatment.Lowconcentrationsofantibioticsenhancedbiofilmformation.Conclusion:A.actinomycetemcomitansJP2homotypicbiofilmsweremoresusceptibleinvitrotodoxycyclinethanamoxicillinmetronidazole.Keywords:Localizedaggressiveperiodontitis;Aggregatibacteractinomycetemcomitans;doxycycline;metronidazole;biofilm(Published:8May2013)Citation:JournalofOralMicrobiology2013,5:20320-http://dx.doi.org/10.3402/jom.v5i0.20320
机译:背景:Localizedaggressiveperiodontitis(LAGP)isaninflammatorydiseaseassociatedwithspecificbacteria,particularlyAggregatibacteractinomycetemcomitans,whichcanresultinearlytoothloss.Thebacteriagrowasabiofilmknownassubgingivalplaque.Treatmentincludesmechanicaldebridementofthebiofilm,oftenassociatedwithempiricalantibiotictreatment.Objective:TheaimsofthisstudyweretotestinvitrothesensitivityofA.actinomycetemcomitansJP2duringplanktonicandbiofilmgrowthtodoxycyclineandtothecombinationofmetronidazoleandamoxicillin,whicharetwoantibioticprotocolscommonlyusedinclinicalpractice.Design:Twoinvitrobiofilmmodelswereusedtotesttheeffectsoftheantibiotics:astatic96-wellplateassaywasusedtoinvestigatetheeffectoftheseantibioticsonbiofilmformationwhilstaflowchambermodelwasusedtoexaminetheeffectonestablishedbiofilms.Results:Oftheantibioticstestedinthismodelsystem,doxycyclinewasmostefficaciouswithaminimalinhibitoryconcentration(MIC)againstplanktoniccellsof0.21mg / Landminimalbiofilminhibitoryconcentration(MBIC) Ø f2.10mg / L.Themostcommonlyprescribedantibioticregimen,amoxicillinmetronidazole,wasmuchlesseffectiveagainstbothplanktonicandbiofilmcellswithanMICandMBICof12.0mg / Land20.2mg / L,respectively.Asingletreatmentoftheclinicallyachievableconcentrationof10mg / LdoxycyclinetosparseA.actinomycetemcomitansbiofilmsintheflowchambermodelresultedinsignificantdecreasesinbiofilmthickness,biovolume,andcellviability.DenseA.actinomycetemcomitansbiofilmsweresignificantlymoreresistanttodoxycyclinetreatment.Lowconcentrationsofantibioticsenhancedbiofilmformation.Conclusion:A.actinomycetemcomitansJP2homotypicbiofilmsweremoresusceptibleinvitrotodoxycyclinethanamoxicillinmetronidazole.Keywords:Localizedaggressiveperiodontitis; Aggregatibacteractinomycetemcomitans;多西环素;甲硝唑;生物膜(2013年5月8日出版)引用:口腔微生物学杂志2013,5:20320-http://dx.doi.org/10.3402/jom.v5i0.20320

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号